Evaluation of Mass Drug Administration Impact on Transmission of Lymphatic Filariasis in 13 Sanitary Districts in Burkina Faso
- 1 Research and Training Unit in Health Sciences, University Ouaga I Pr Joseph Ki-Zerbo, Ouagadougou, Burkina Faso
- 2 Research and Training Unit in Health Sciences, University Ouaga I Pr Joseph Ki-Zerbo, Ouagadougou, Burkina Faso
- 3 Research and Training Unit in Health Sciences, University Ouaga I Pr Joseph Ki-Zerbo, Ouagadougou, Burkina Faso
- 4 Neglected Tropical Diseases National Program, Lymphatic Filariasis Unit, Ouagadougou, Burkina Faso
- 5 Neglected Tropical Diseases National Program (NTD NP), Ouagadougou, Burkina Faso
- 6 Neglected Tropical Diseases National Program (NTD NP), Ouagadougou, Burkina Faso
- 7 University Hospital of Tengandogo, Ouagadougou, Burkina Faso
- 8 Neglected Tropical Diseases National Program (NTD NP), Ouagadougou, Burkina Faso
- 9 Neglected Tropical Diseases National Program (NTD NP), Ouagadougou, Burkina Faso
- 10 Neglected Tropical Diseases National Program (NTD NP), Ouagadougou, Burkina Faso
Abstract
Introduction : Lymphatic filariasis (LF) is one of the neglected tropical diseases targeted for elimination as a public health issue in the world by 2020. To achieve this goal, one of the strategies is interruption of transmission using chemotherapy (mass drug administration). Burkina Faso in west Africa, an endemic country, has endorsed this resolution. In 2000, all Sanitary Districts (SD) in the country were endemic, and then a national elimination program has made it possible to stop mass treatment in 45 out of 70 SD over 12 years. Sixteen years later, 13 other SD were re eligible for Transmission Assessment Surveys (TAS) . This study aimed to determine the current level of the Mass drugs Administration (MDA) impact indicators in these 13 targeted SD in order to decide whether we need to continue MDA. Method : It was a descriptive study that took place from June to September 2017 in 13 SD regrouped into 7 Evaluation Units (EU). The population of the study was 6 to 7 years old children. The community-based cluster survey method was used. The diagnostic test used to detect Wuchereria bancrofti ’ s circulating antigen ( W. bancrofti ) is the F i lariasis Test Strip (FTS). The critical threshold of positivity was set at 18 positive subjects per EU. Results : We sampled a total of 12 , 060 children, 48.9% were female and 51.1% male. In the 7 EU, 13 children were positive to W. bancrofti test. The average antigenic prevalence was 0.11% (13/12 , 060). In all EU, the number of positive subjects was below the critical threshold. Conclusion : At the end of this evaluation of the transmission of lymphatic filariasis in 13 SD of Burkina Faso, we can tell the MDA could be stopped in these areas without risk of resurgence of the disease, according to the current recommendations of WHO. This can be possible by setting up post-TMM surveillance, considering migratory flows, and including villages where positive cases were found to search possible residual transmission zones.
- http://www.who.int/neglected_diseases/mediacentre/WHA_50.29_Eng.pdf
- WHO Epidemiological Monitoring and Evaluation of Mass Drug Therapy in the Global Program to Eliminate Lymphatic Filariasis: Handbook for National Phase-Out Programs 2013, 10.
- Neglected Tropical Diseases National Program of Burkina Faso. Lymphaticfilariasis Mass Drug Administration Database 2001-2016.
- Neglected Tropical Diseases National Program, 2016 Annual Report.
- Task Force for Global Health, User Guide to Survey Sample Builder v2. http://www.ntdsupport.org/sites/default/files/uploads/docs/resources/SSB%20User%20Guide%20V2.1_0.pdf
- Chu, B.K., Deming, M., Biritwum, N.K., Bougma, W.R., Dorkenoo, A.M., et al. (2013) Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation. PLOS Neglected Tropical Diseases, 7, e2584.
- Neglected Tropical Diseases National Program of Burkina Faso. Lymphaticfilariasis Database 2009-2016.
- Ramaiah,K.D. (2013) Population Migration: Implications for Lymphatic Filariasis Elimination Programmes. PLOS Neglected Tropical Diseases, 7, e2079.
- Esterre, P., Plichart, C., Sechan, Y. and Nguyen, N.L. (2001) The Impact of 34 Years of Massive DEC Chemotherapy on Wuchereria bancrofti Infection and Transmission: The Maupiticohort. Tropical Medicine & International Health, 6, 190-195. https://doi.org/10.1046/j.1365-3156.2001.00682.x
- Hadee, D.D., Tilluckdharry, C.C., Rawlins, S.C., Doon, R. and Nathan, M.B. (1995) Mass Chemotherapy with Diethylcarbamazine for the Control of Bancroftiafilariasis: A Twelve-Year Follow-Up in Northern Trinidad, including Observations on Mansonellaozzardi. The American Journal of Tropical Medicine and Hygiene, 52, 174-176. https://doi.org/10.4269/ajtmh.1995.52.174
- Rawlins, S.C., Siung-Chang, A., Baboolal, S. and Chadee, D.D. (2004) Evidence for the Interruption of Transmission of Lymphatic Filariasis among Schoolchildren in Trinidad and Tobago. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98, 473-477. https://doi.org/10.1016/j.trstmh.2003.11.006
- Triteeraprapab, S. and Songtrus, J. (2001) High Prevalence of Wuchereria bancrofti Infection among Myanmar Migrants in Thailand. Annals of Tropical Medicine & Parasitology, 95, 535-538. https://doi.org/10.1080/00034983.2001.11813666
- Sunish, I.P., Rajendran, R., Mani, T.R., Gajanana, A., Reuben, R., et al. (2003) Long-Term Population Migration: An Important Aspect to Be Considered during Mass Drug Administration for Elimination of Lymphaticfilariasis. Tropical Medicine & International Health, 8, 316-321. https://doi.org/10.1046/j.1365-3156.2003.01033.x